The expression of RhoC and Ki67 in cervical intraepithelial neoplasia and squamous carcinoma of cervix

Journal of Sichuan University (Medical Science)

Volumn 40, Issue 2, 2009, Pages 236-239

  Nai, Man Man ^a   Yin, Ru Tie ^a   Xie, Cong ^a   Kang, De Ying ^a   Tang, Xiao Li ^a  

^a SICHUAN UNIVERSITY   (China)

Author keywords

Invasion and metastasis; Ki67; Rhoc; Squamous carcinoma of cervix

Indexed keywords

KI 67 ANTIGEN; RHO GUANINE NUCLEOTIDE BINDING PROTEIN; RHOC PROTEIN, HUMAN; TUMOR MARKER;

ADULT; AGED; FEMALE; GENETICS; HUMAN; METABOLISM; METASTASIS; MIDDLE AGED; PATHOLOGY; SQUAMOUS CELL CARCINOMA; TUMOR INVASION; UTERINE CERVIX CARCINOMA IN SITU; UTERINE CERVIX TUMOR; YOUNG ADULT;

ADULT; AGED; CARCINOMA, SQUAMOUS CELL; CERVICAL INTRAEPITHELIAL NEOPLASIA; FEMALE; HUMANS; KI-67 ANTIGEN; MIDDLE AGED; NEOPLASM INVASIVENESS; NEOPLASM METASTASIS; RHO GTP-BINDING PROTEINS; TUMOR MARKERS, BIOLOGICAL; UTERINE CERVICAL NEOPLASMS; YOUNG ADULT;

EID: 63449096884     PISSN: 1672173X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (13)

1. Chinese source
2. Shimizu M, Saitoh Y, Itoh H. Immunohistochemical staining of Ha-ras oncogene product in normal, benign and malignant human pancreatic tissues. Hum Pathol, 1990;(21(6).-607-612.
3. Carrearas R, Alameda F, Mancebo G, et al. A study of Ki-67, c-erbB2 and cyclin D- l expression in CIN- I, cin-III and squamous cell carcinoma of the cervix. Histol Histopathol, 2007,22(6):587-592.
4. DerMardirossian C, Bokoch GM. GDIs : central regulatory molecules in Rho GTPase activation. Trends In Cell Biology, 2005,15(7),356-363.
5. Ridley AJ, Schwartz MA, Burridge K, et al. Cell migration, integrating signals from front to back. Science, 2003; 302 (5651) :1704-1709.
6. Ridley AJ. Rho GTPases and cell migration. Journal of Cell Science, 2001;114(Pt 15) :2713-2722.
7. Kleer CG, van Golen KL, Zhang Y, et al. Characterization of RhoC expression in benign and malignant breast disease, a potential new marker for small breast carcinomas with metastatic ability. American Journal of Pathology, 2002; 160 (2):579-584.
8. Megumi I, Sucharita B, Shigeru H, et al. Expression of RhoC correlates with metastatic disease and survival of prostate cancer patients. Proc Amer Assoc Cancer Res, 2006; 47 (25) : 827-828.
9. Kleer CG,Teknos TN,Islam M, et al. RhoC GTPase expression as a potential marker of lymph node metastasis in squamous cell carcinomas of the head and neck. Clinical Cancer Research, 2006;12(15),4485-4490.
10. Wang W, Yang LY, Huang GW, et al. Genomic analysis reveals RhoC as a potential marker in hepatocellular carcinoma with poor prognosis. British Journal of Cancer, 2004; 90 (12):2349-2355.
11. Chinese source
12. Horiuchi A, Imai T, Wang C, et al. Up-regulation of small GTPases, RhoA and RhoC, is associated with tumor progression in ovarian carcinoma. Laboratory Investigation, 2003;83(6):861-870.
13. Chinese source